As the founder and chairman of Alves Group, a key Indian player in medical devices with an extensive portfolio, Randolph Alves shares the challenges India needs to overcome to remain a competitive exporter. With great ambitions for Alves, he further explains how critical the international stage - especially the African market - is in contributing to the growth of the company in the five years to come.
The Indian pharmaceutical industry has been extremely successful over the past 15 years on the global stage, thereby concurring many emerging and regulated markets. How would you explain such rapid success?
"As we intend to grow within the next five years, our first challenge to overcome will be our cash flow, which means that we need to raise funds for our international and domestic projects."
